| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.031 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.029 | 0.8 |